| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.21B | +35.7% |
| Cost of Revenue | $1.70B | +17.6% |
| R&D Expense | $911.9M | +0.3% |
| SG&A Expense | $915.6M | -3.2% |
| Operating Income | -$1.14B | +37.2% |
| Interest Expense | $51.6M | +58.0% |
| Pre-tax Income | -$1.05B | +41.5% |
| Income Tax | $11.2M | +125.2% |
| Net Income | -$1.06B |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $457.3M | +43.0% |
| Short-term Investments | $1.80B | -7.0% |
| Current Assets | $2.78B | +7.0% |
| Total Assets | $4.77B | +2.0% |
| Current Liabilities | $2.52B | +21.3% |
| Long-term Debt | $711.4M | +4.6% |
| Total Liabilities | $3.43B | +14.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$101.7M | +92.6% |
| Investing Cash Flow | $267.0M | -63.9% |
| Financing Cash Flow | -$72.5M | -114.1% |
| +39.4% |
| EPS (Basic) | -$3.17 | +43.5% |
| EPS (Diluted) | -$3.17 | +43.5% |
| Stockholders' Equity |
| $1.34B |
| -20.0% |